183 related articles for article (PubMed ID: 27845349)
21. Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: a meta-analysis of randomized controlled trials.
Kang S; Yang Y; Li CJ; Gao R
Clin Ther; 2007 Nov; 29(11):2406-18. PubMed ID: 18158081
[TBL] [Abstract][Full Text] [Related]
22. AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke.
Schäbitz WR; Laage R; Vogt G; Koch W; Kollmar R; Schwab S; Schneider D; Hamann GF; Rosenkranz M; Veltkamp R; Fiebach JB; Hacke W; Grotta JC; Fisher M; Schneider A
Stroke; 2010 Nov; 41(11):2545-51. PubMed ID: 20947859
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotective effect of granulocyte-colony stimulating factor.
Solaroglu I; Jadhav V; Zhang JH
Front Biosci; 2007 Jan; 12():712-24. PubMed ID: 17127331
[TBL] [Abstract][Full Text] [Related]
24. Cerebrolysin for acute ischaemic stroke.
Ziganshina LE; Abakumova T; Vernay L
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD007026. PubMed ID: 27918088
[TBL] [Abstract][Full Text] [Related]
25. Neuroprotective therapy using granulocyte colony-stimulating factor for patients with worsening symptoms of thoracic myelopathy: a multicenter prospective controlled trial.
Sakuma T; Yamazaki M; Okawa A; Takahashi H; Kato K; Hashimoto M; Hayashi K; Furuya T; Fujiyoshi T; Kawabe J; Mannoji C; Miyashita T; Kadota R; Someya Y; Ikeda O; Yamauchi T; Hashimoto M; Aizawa T; Ono A; Imagama S; Kanemura T; Hanaoka H; Takahashi K; Koda M
Spine (Phila Pa 1976); 2012 Aug; 37(17):1475-8. PubMed ID: 22652593
[TBL] [Abstract][Full Text] [Related]
26. Granulocyte-colony stimulating factor in acute-on-chronic liver failure: Systematic review and meta-analysis of randomized controlled trials.
Martin-Mateos R; González-Alonso R; Álvarez-Díaz N; Muriel A; Gaetano-Gil A; Donate Ortega J; López-Jerez A; Figueroa Tubio A; Albillos A
Gastroenterol Hepatol; 2023 May; 46(5):350-359. PubMed ID: 36174797
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of GABA
Chabriat H; Bassetti CL; Marx U; Audoli-Inthavong ML; Sors A; Lambert E; Wattez M; Hermann DM;
Lancet Neurol; 2020 Mar; 19(3):226-233. PubMed ID: 32085836
[TBL] [Abstract][Full Text] [Related]
28. Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis.
Zohlnhöfer D; Dibra A; Koppara T; de Waha A; Ripa RS; Kastrup J; Valgimigli M; Schömig A; Kastrati A
J Am Coll Cardiol; 2008 Apr; 51(15):1429-37. PubMed ID: 18402895
[TBL] [Abstract][Full Text] [Related]
29. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial.
Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM
J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910
[TBL] [Abstract][Full Text] [Related]
30. Brain repair by hematopoietic growth factors in the subacute phase of traumatic brain injury.
Toshkezi G; Kyle M; Longo SL; Chin LS; Zhao LR
J Neurosurg; 2018 Nov; 129(5):1286-1294. PubMed ID: 29372883
[TBL] [Abstract][Full Text] [Related]
31. Neuroprotective therapy with granulocyte colony-stimulating factor in acute spinal cord injury: a comparison with high-dose methylprednisolone as a historical control.
Kamiya K; Koda M; Furuya T; Kato K; Takahashi H; Sakuma T; Inada T; Ota M; Maki S; Okawa A; Ito Y; Takahashi K; Yamazaki M
Eur Spine J; 2015 May; 24(5):963-7. PubMed ID: 24961222
[TBL] [Abstract][Full Text] [Related]
32. Circulating granulocyte colony-stimulating factor and functional outcome after ischemic stroke: an observational study.
Wall A; Anger O; Jood K; Blomstrand C; Andreasson U; Blennow K; Zetterberg H; Isgaard J; Jern C; Åberg ND; Svensson J
Neurol Res; 2021 Dec; 43(12):1013-1022. PubMed ID: 34253146
[No Abstract] [Full Text] [Related]
33. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.
Bohlius J; Reiser M; Schwarzer G; Engert A
Cochrane Database Syst Rev; 2004; (3):CD003189. PubMed ID: 15266474
[TBL] [Abstract][Full Text] [Related]
34. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
Renner P; Milazzo S; Liu JP; Zwahlen M; Birkmann J; Horneber M
Cochrane Database Syst Rev; 2012 Oct; 10():CD007913. PubMed ID: 23076939
[TBL] [Abstract][Full Text] [Related]
35. Granulocyte-colony stimulating factor (G-CSF) in stroke patients with concomitant vascular disease--a randomized controlled trial.
Floel A; Warnecke T; Duning T; Lating Y; Uhlenbrock J; Schneider A; Vogt G; Laage R; Koch W; Knecht S; Schäbitz WR
PLoS One; 2011; 6(5):e19767. PubMed ID: 21625426
[TBL] [Abstract][Full Text] [Related]
36. Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site Group.
Rusthoven J; Bramwell V; Stephenson B
Cancer Prev Control; 1998 Aug; 2(4):179-90. PubMed ID: 10093631
[TBL] [Abstract][Full Text] [Related]
37. Granulocyte-Colony Stimulating Factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults.
Cheng AC; Stephens DP; Currie BJ
Cochrane Database Syst Rev; 2004; (3):CD004400. PubMed ID: 15266532
[TBL] [Abstract][Full Text] [Related]
38. Cerebrolysin for acute ischaemic stroke.
Ziganshina LE; Abakumova T; Vernay L
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007026. PubMed ID: 28430363
[TBL] [Abstract][Full Text] [Related]
39. Study protocol for the G-SPIRIT trial: a randomised, placebo-controlled, double-blinded phase III trial of granulocyte colony-stimulating factor-mediated neuroprotection for acute spinal cord injury.
Koda M; Hanaoka H; Sato T; Fujii Y; Hanawa M; Takahashi S; Furuya T; Ijima Y; Saito J; Kitamura M; Ohtori S; Matsumoto Y; Abe T; Watanabe K; Hirano T; Ohashi M; Shoji H; Mizouchi T; Takahashi I; Kawahara N; Kawaguchi M; Orita Y; Sasamoto T; Yoshioka M; Fujii M; Yonezawa K; Soma D; Taneichi H; Takeuchi D; Inami S; Moridaira H; Ueda H; Asano F; Shibao Y; Aita I; Takeuchi Y; Mimura M; Shimbo J; Someya Y; Ikenoue S; Sameda H; Takase K; Ikeda Y; Nakajima F; Hashimoto M; Ozawa T; Hasue F; Fujiyoshi T; Kamiya K; Watanabe M; Katoh H; Matsuyama Y; Yamamoto Y; Togawa D; Hasegawa T; Kobayashi S; Yoshida G; Oe S; Banno T; Arima H; Akeda K; Kawamoto E; Imai H; Sakakibara T; Sudo A; Ito Y; Kikuchi T; Osaki S; Tanaka N; Nakanishi K; Kamei N; Kotaka S; Baba H; Okudaira T; Konishi H; Yamaguchi T; Ito K; Katayama Y; Matsumoto T; Matsumoto T; Idota M; Kanno H; Aizawa T; Hashimoto K; Eto T; Sugaya T; Matsuda M; Fushimi K; Nozawa S; Iwai C; Taguchi T; Kanchiku T; Suzuki H; Nishida N; Funaba M; Yamazaki M
BMJ Open; 2018 May; 8(5):e019083. PubMed ID: 29730616
[TBL] [Abstract][Full Text] [Related]
40. Impact on acute myeloid leukemia relapse in granulocyte colony-stimulating factor application: a meta-analysis.
Feng X; Lan H; Ruan Y; Li C
Hematology; 2018 Oct; 23(9):581-589. PubMed ID: 29516766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
